Logo image
A randomised comparison of the Ambu® AuraGain™ and the LMA® supreme in infants and children
Journal article   Peer reviewed

A randomised comparison of the Ambu® AuraGain™ and the LMA® supreme in infants and children

N. Jagannathan, J. Hajduk, L. Sohn, A. Huang, A. Sawardekar, E.R. Gebhardt, K. Johnson and G.S. De Oliveira
Anaesthesia, Vol.71(2)
2016

Abstract

Airway Management Child Child, Preschool Equipment Design Female Fiber Optic Technology Humans Infant Laryngeal Masks Male airway obstruction Article artificial ventilation body height body weight bronchospasm child clinical practice comparative effectiveness controlled study coughing dysphonia end tidal carbon dioxide tension endotracheal intubation female human infant laryngeal mask larynx spasm major clinical study male pediatric anesthesia peroperative complication postoperative complication pressure measurement randomized controlled trial stomach tube stridor upper respiratory tract obstruction comparative study devices equipment design fiber optics laryngeal mask preschool child respiration control statistics and numerical data
We conducted a randomised trial in 100 children in order to compare the clinical performance of the Ambu® AuraGain™ and the LMA® Supreme∗ for airway maintenance during mechanical ventilation. The primary outcomes were initial and 10-min airway leak pressures. Ease, time and success rates for device and gastric tube insertion, fibreoptic grades of view, airway quality during anaesthetic maintenance, and complications were also assessed. There were no differences in the initial and ten min airway leak pressures between the Ambu AuraGain and LMA Supreme, median (IQR [range]) initial: 19 (16-22 [10-34]) vs 18 (14-24 [8-40]) cmH2O, p = 0.4; and ten min: 22 (18-26 [11-40]) vs 20 (16-26 [12-40]) cmH2O, p = 0.08, respectively. Ease, time and success rates for device placement, gastric tube insertion and complications were also not significantly different. Children receiving the LMA Supreme required more airway manouevers (7 vs 1 patient, p = 0.06) to maintain a patent airway. Our results suggest that the Ambu AuraGain may be a useful alternative to the LMA Supreme, as demonstrated by comparable overall clinical performance in children. © 2015 The Association of Anaesthetists of Great Britain and Ireland.

Metrics

4 Record Views

Details

Logo image